D&D Pharmatech Inc.

₩37,750As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:347850Healthcare
Country South Korea
PE (Fwd) •••
TSR 2Y CAGR 98.08%
Div yield —
ROE (20.48%)
Biotechnology
Beta (5Y) 1.66
PE TTM —
TSR TTM (45.68%)
Mkt cap ₩1.730T
ROIC (49.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩36,496
(3.32%)
(30.08%)
Hold 8|2|7|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
479.29
490.54
508.98
499.13
11.53%
18.19%
14.49%
0.85%
Revenue₩B
106.8
111.8
114.0
116.0
3.33%
6.03%
7.17%
8.35%
Peers (US$1.276B)
Cap (US$)
PE
1.488B
—
1.274B
—
1.277B
—
Capital
TTM
5Y
10Y
Leveragex
0.422
0.074
0.076
EBIT/Intx
1.756
0.178
0.183
Own earn%
13.61
52.44
57.59
Sh yield%
34.27
15.02
20.08
Owners
Insiders/Inst%
5.73
87.87
Short interest%
3.96
SBC / revenue%
0.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
22–27
$1 testx
−0.2
Incr. ROIC%
1